BAL bellamy's australia limited
Add to My Watchlist 0.00% ! $13.23

FY18 Guide & Annual Results, page-4

  1. 8horse
    34,449 Posts.
    lightbulb Created with Sketch. 9344
    clock Created with Sketch.
    27/08/18
    15:38
    Post #: 35209694
    On 21 February 2018, the company announced they expected CFDA approval to take six months or longer. Then share price was still pushed up from $15 to $23/share. You would expect share price to drop that time.
    By now, six months passed, CFDA approval is more close, Why share price would drop? especially along with strong annual results.
    Share price should be building up towards CFDA approval, imo, next batch of CFDA/SAMR approval should be released around September/October 2018.
    Last edited by 8horse: 27/08/18
    BAL Price at posting: $10.12 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 6  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Listen: HotCopper Wire Podcast 017 – RBA holds the toppings
right-arrow Created with Sketch.
NEWS Rincon Lithium Project to be powered by 40MW energy infrastructure
right-arrow Created with Sketch.
NUZ Positive FDA feedback on NUZ-001 strategy to lift clinical hold
right-arrow Created with Sketch.
NEWS Trump just dropped a 200% tariff bomb. Here's how to cash in
right-arrow Created with Sketch.
CC9 Chariot to Acquire Majority Stake in a Nigerian Lithium Portfolio
right-arrow Created with Sketch.
NEWS Significant gold intercepts below Samat and Sorowar pits in resource drilling update
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.